Targetable Driver Mutations in Multicentric Reticulohistiocytosis

Haematologica - Italy
doi 10.3324/haematol.2019.218735
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Thalidomide, a Rational Agent for Treatment of Multicentric Reticulohistiocytosis

Dermatology Case Reports
2019English

Multicentric Reticulohistiocytosis in the Course of Undifferentiated Connective Tissue Disease

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2019English

Driver Mutations in Melanoma

Libri Oncologici
Oncology
2018English

Somatic Driver Mutations in Melanoma

Cancer
Cancer ResearchOncology
2017English

Comprehensive Analysis of Targetable Oncogenic Mutations in Chinese Cervical Cancers

Oncotarget
Oncology
2015English

New Driver Mutations Detected in NSCLC

Cancer Discovery
Oncology
2016English

Multicentric Origin of Hemochromatosis Gene (HFE) Mutations

American Journal of Human Genetics
Genetics
1999English

Reticulohistiocytosis

Acta Radiologica
1957English

ARID1A Gene Driver Mutations in Lung Adenocarcinomas

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy